Can Pharmacogenetic Testing Optimize Pain Management?
Raeesa Gupte, PhD | Aug 30, 2021
Harnessing the power of pharmacogenomics may make opioid analgesics safer and more effective
Next Generation Sequencing (NGS)
Ongoing Testing for Long-Term Control of COVID-19 Post Vaccination
Nico Tuason, BSc | Aug 27, 2021
Continued SARS-CoV-2 surveillance is vital to stemming potential new outbreaks
Solving Rare Disease Mysteries with Genomics
Brydie Thomas-Moore, PhD | Aug 03, 2021
The Solve-RD consortium is striving to improve rare disease diagnostics using genomics
Biostatistical Methodology Accurately Flags More Deadly SARS-CoV-2 Variant
Harvard T.H. Chan School of Public Health | Jun 23, 2021
Genome-wide association studies could enable better real time detection of novel viral variants in pandemics
COVID-19 Variants—Diagnostics and Surveillance
Suzanne Leech, PhD | Jun 09, 2021
Several variants of concern are circulating in the US—labs must remain vigilant of variants that affect testing
Where Coronavirus Variants Emerge, Surges Follow
Bart C. Weimer, Darwin Bandoy | May 10, 2021
Research suggests genomic surveillance can be an early warning system for COVID-19
Genomic Surveillance: Why We Need More of It to Help End the Pandemic
Alexander Sundermann, Vaughn Cooper | May 06, 2021
The CDC is partnering with private, state, and local public health labs to increase genomic surveillance in the US
Clinical Organizations Release SARS-CoV-2 Variant Sequencing Guidelines
Miriam Bergeret, MSc | Apr 30, 2021
The rapid communication provides laboratory professionals with guidance on sequencing COVID-19 variants
How Tumors Respond to Hypoxia
Erica Tennenhouse, PhD | Apr 26, 2021
Researchers investigate whether oxygen deprivation promotes or prevents tumor growth
How Northeastern University Became a Leader in On-Campus COVID-19 Testing
Miriam Bergeret, MSc | Apr 22, 2021
After building a CLIA-certified lab in six weeks, NU has gone on to complete more than 975,000 COVID-19 tests